GenKyoTex – Exit
GenKyoTex is a product-driven biopharmaceutical company dedicated to the development of innovative therapeutics blocking the source of production of oxygen radicals in a specific manner to meet unmet medical need.
| Sector: | Therapeutics |
| Country: | Switzerland / France |
| Status: | IPO on Euronext |